24/7 Market News Snapshot 13 January, 2025 – NEVRO CORP. (NYSE:NVRO)
DENVER, Colo., 13 January, 2025 (247marketnews.com) – (NYSE:NVRO) are discussed in this article.
Nevro Corp has experienced a significant surge in trading activity, with shares climbing to $4.005, marking a remarkable 21.73% increase from the previous close of $3.29. This rise, characterized by a current trading volume of 1.02 million shares, reflects heightened investor interest and optimism surrounding the company’s innovative neuromodulation solutions. Market watchers are closely monitoring this positive momentum, which signals a favorable outlook for Nevro amidst evolving market conditions.
In addition to this trading performance, Nevro has released preliminary financial results for the fourth quarter and full year of 2024. The company anticipates fourth-quarter revenues of approximately $105 million to $106 million, indicating a year-over-year decline of 9% to 10%. However, U.S. revenues are projected to be around $91 million to $92 million, showcasing resilience in a challenging industry landscape.
For the full year, Nevro expects worldwide revenue to fall between $408 million and $409 million, reflecting a modest decrease of about 4% year-over-year. Notably, the company has exceeded its prior guidance, driven by an uptick in spinal cord stimulation (SCS) device replacement procedures toward the end of the year. Moreover, Nevro’s cash reserves have strengthened, with estimates of cash, cash equivalents, and short-term investments reaching approximately $292.5 million, an increase of about $15.5 million since September 30, 2024.
CEO Kevin Thornal expressed confidence in the company’s strategic direction, highlighting a successful reallocation towards direct-to-consumer advertising, which is anticipated to enhance patient engagement significantly throughout 2025. Nevro’s commitment to innovation in chronic pain management continues to position it for future growth and value creation, with further insights expected during the upcoming earnings call in early March 2025.